GERN Geron Corp

Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.

$2.33  +0.07 (3.10%)
As of 09/27/2022 10:11:32 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  377,818,875
Average volume:  4,476,108
Market cap:   $868,983,412
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2370381
Valuation   (See tab for details)
PE ratio:   -7.34
PB ratio:   7.64
PS ratio:   0.00
Return on equity:   -2.45%
Net income %:   -15,257.66%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy